Norway
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
0.78
|
Dec. 31, 2023 | USD 2.12 | -1.52% |
|
Norway |
|
2 |
0.14
|
Dec. 31, 2023 | USD 1.06 | -3.51% |
|
Norway |
|
3 |
0.09
|
Dec. 31, 2023 | USD 3.68 | -8.83% |
|
Norway |
|
4 |
0.04
|
Dec. 31, 2023 | USD 13.86 | -1.83% |
|
Norway |
|
5 |
0.04
|
Dec. 31, 2023 | USD 1.26 | -2.07% |
|
Norway |
|
6 |
0.04
|
Dec. 31, 2023 | USD 4.93 | -3.23% |
|
Norway |
|
7 |
0.01
|
Dec. 31, 2023 | USD 0.19 | -2.43% |
|
Norway |
The Healthcare company in Norway with the highest Debt to Equity Ratio is Navamedic ASA (Oslo Stock Exchange: NAVA.OL) at 0.78.
The Healthcare company in Norway with the lowest Debt to Equity Ratio is Ultimovacs ASA (Oslo Stock Exchange: ULTI.OL) at 0.01.
The top 10 Healthcare companies in Norway by Debt to Equity Ratio are Navamedic ASA, Lifecare AS, Gentian Diagnostics ASA, Medistim ASA, ArcticZymes Technologies ASA, Photocure ASA and Ultimovacs ASA.
The bottom 10 Healthcare companies in Norway by Debt to Equity Ratio are Ultimovacs ASA, Photocure ASA, ArcticZymes Technologies ASA, Medistim ASA, Gentian Diagnostics ASA, Lifecare AS and Navamedic ASA.